Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, reflecting a small internal update to the page record without changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T09:56:28.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The study status is updated to Completed, and new dates/metadata were added (Study Completion Actual: 2023-04-26; latest updates: 2026-05-11 and 2026-05-13; Revision: v3.5.4).
    Difference
    0.5%
    Check dated 2026-05-14T23:07:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    - Revision: v3.5.3 supersedes v3.5.2, indicating a minor administrative update to the study record on ClinicalTrials.gov. - The update does not change any study details or user-visible content.
    Difference
    0.1%
    Check dated 2026-04-30T15:45:09.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2, replacing the previous v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:51.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added a Hepatocellular carcinoma tag and a link to the Genetic and Rare Diseases Information Center; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:12:56.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:06.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.